Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Xencor Inc (NQ: XNCR ) 21.65 +0.38 (+1.79%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Xencor Inc < Previous 1 2 3 4 5 6 Next > Xencor Reports First Quarter 2022 Financial Results May 05, 2022 From Xencor, Inc. Via Business Wire The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study May 05, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Earnings Scheduled For May 5, 2022 May 05, 2022 Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million. Via Benzinga Xencor: Q4 Earnings Insights February 23, 2022 Xencor (NASDAQ:XNCR) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings Xencor... Via Benzinga Xencor's Earnings Outlook May 04, 2022 Xencor (NASDAQ:XNCR) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Xencor will report... Via Benzinga Stocks That Hit 52-Week Lows On Wednesday May 04, 2022 During Wednesday's trading, 435 companies set new 52-week lows. Via Benzinga Xencor to Host First Quarter 2022 Financial Results Webcast and Conference Call on May 5, 2022 April 28, 2022 From Xencor, Inc. Via Business Wire Stocks That Hit 52-Week Lows On Monday April 18, 2022 On Monday, 466 companies hit new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was... Via Benzinga Xencor Presents Data from Multiple Preclinical XmAb® Cytokine Programs at the American Association for Cancer Research (AACR) Annual Meeting 2022 April 08, 2022 From Xencor, Inc. Via Business Wire Stocks That Hit 52-Week Lows On Tuesday March 15, 2022 During Tuesday's session, 454 stocks hit new 52-week lows. Intriguing Points From Today's 52-Week Lows: Taiwan Semiconductor (NYSE:TSM) was the largest company by... Via Benzinga Stocks That Hit 52-Week Lows On Tuesday March 08, 2022 Tuesday's session saw 729 companies set new 52-week lows. Areas of Interest About Today's 52-Week Lows: Amazon.com (NASDAQ:AMZN) was the largest firm on a... Via Benzinga Stocks That Hit 52-Week Lows On Monday March 07, 2022 On Monday, 524 stocks hit new 52-week lows. Areas of Interest About Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was Taiwan... Via Benzinga Xencor Reports Fourth Quarter and Full Year 2021 Financial Results February 23, 2022 From Xencor, Inc. Via Business Wire Xencor to Report Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call on February 23, 2022 February 16, 2022 From Xencor, Inc. Via Business Wire Stocks That Hit 52-Week Lows On Friday March 04, 2022 On Friday, 368 stocks hit new 52-week lows. Interesting Points From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was... Via Benzinga Xencor to Present at Upcoming Investor Conferences February 02, 2022 From Xencor, Inc. Via Business Wire Earnings Scheduled For February 23, 2022 February 23, 2022 Companies Reporting Before The Bell • Sapiens Intl Corp (NASDAQ:SPNS) is likely to report earnings for its fourth quarter. • Plymouth Industrial REIT (NYSE:PLYM)... Via Benzinga Xencor Highlights 2022 Corporate Priorities and Portfolio Milestones January 11, 2022 From Xencor, Inc. Via Business Wire Xencor to Present at the H.C. Wainwright Bioconnect Virtual Conference January 06, 2022 From Xencor, Inc. Via Business Wire Xencor Presents Data from Phase 1 Study of Plamotamab in B-cell Non-Hodgkin Lymphomas at the ASH Annual Meeting December 12, 2021 From Xencor, Inc. Via Business Wire Week In Review: Shanghai's Zenas Acquires CD19 Antibody From Xenco In $480 Million Deal November 27, 2021 In a $480 million deal, Zenas acquired global rights to a bifunctional antibody from Xencor that targets CD19. Instead of an upfront payment, Zenas will issue a warrant granting Xencor the right to... Via Talk Markets Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021 December 15, 2021 Upgrades B of A Securities upgraded the previous rating for ONE Gas Inc (NYSE: Via Benzinga Pfizer Sues Former Employee For Stealing Confidential Info On Its Megablockbuster COVID-19 Vaccine November 24, 2021 Pfizer Inc (NYSE: PFE) has sued its former associate director of clinical statistics in a California court to get a handle on allegedly stolen information. The Company's... Via Benzinga Topics Lawsuit Exposures COVID-19 Financial Legal Xencor Outlicenses Autoimmune Disease Candidate To Zenas BioPharma November 22, 2021 Zenas BioPharma has acquired from Xencor Inc (NASDAQ: XNCR) exclusive worldwide rights to develop, manufacture, and commercialize obexelimab. Obexelimab is a... Via Benzinga Zenas BioPharma Acquires Exclusive Worldwide Rights to Obexelimab from Xencor November 21, 2021 From Xencor, Inc. Via Business Wire Xencor to Present at Upcoming Investor Conferences November 19, 2021 From Xencor, Inc. Via Business Wire Xencor Presents Updated Data from the Phase 1 Study of Vudalimab, PD-1 x CTLA-4 Bispecific Antibody, at the SITC Annual Meeting November 12, 2021 From Xencor, Inc. Via Business Wire Xencor Presents Data from Multiple Preclinical XmAb® Bispecific Antibody Programs and IL-12 Cytokine, XmAb662, at the SITC Annual Meeting November 12, 2021 From Xencor, Inc. Via Business Wire Novartis Dumps Another Bispecific Candidate From Xencor Deal November 09, 2021 Novartis AG (NYSE: NVS) terminated its ex-US rights to the program dubbed vibecotamab, a bispecific targeting CD123 and CD3 for acute myeloid leukemia. The... Via Benzinga Xencor, inc (XNCR) Q3 2021 Earnings Call Transcript November 08, 2021 XNCR earnings call for the period ending September 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.